Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023. First-quarter GAAP diluted EPS of $0.75 and...
Stay updated with breaking news from Rapid Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2023. First-quarter GAAP diluted EPS of $0.75 and...
/PRNewswire/ -- The "Cardiac Troponin Diagnostics - Forecasts and Opportunities to 2025" report has been added to ResearchAndMarkets.com's offering. Cardiac...
/PRNewswire/ -- The "Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth...
/PRNewswire/ -- The "Global Rapid Diagnostics Market 2021-2031 by Product, Prescription, Platform, Application, End User, and Region: Trend Forecast and Growth...
/PRNewswire/ -- The "Global Monkeypox Diagnostics Market by Assay, Country, Product, and Place, with Executive & Consultant Guides and Market Analysis &...